Echocardiography in Fabry disease: Diagnostic value of endocardial border binary appearance

Clinical Physiology and Functional Imaging

Volumn 29, Issue 3, 2009, Pages 177-180

  Koskenvuo, Juha W ^a   Engblom, Erik ^a   Kantola, Ilkka M ^a   Hartiala, Jaakko J ^a   Saraste, Antti ^a   Kiviniemi, Tuomas O ^a   Mononen, Ilkka ^a   Saraste, Markku ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Binary; Diagnosis; Endocardium; Fabry disease; Hyperechoic; Transthoracic echocardiography

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSPNEA; ENDOCARDIUM; FABRY DISEASE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; ENDOCARDIUM; FABRY DISEASE; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 63349109591     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2008.00851.x     Document Type: Article

References (14)

1. Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, Goldfarb L, Brady RO, Balow JE, Austin Iii HA, Kopp JB. Natural history of fabry renal disease: Influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) (2002); 81: 122-138.
2. Desnick RJ, Allen KY, Desnick SJ, Raman MK, Bernlohr RW, Krivit W. Fabry's disease: Enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med (1973); 81: 157-171.
3. Desnick RJ, Ioannou YA, Eng ME. Alfa-galactosidase a deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease (eds Scriver, CR, Beaudet, AL, Sly, D, Valle, D) (2001), pp. 3733-3774. McGraw-Hill, New York.
4. Kawashima I, Takeuchi I, Ohsawa M, Kotani M, Tajima Y, Inomata T, Izumi T, Sakuraba H. Phospholipid storage in the myocardium of a unique japanese case of idiopathic cardiomyopathy. Clin Chim Acta (2006); 372: 154-157.
5. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, European Association of Echocardiography. Recommendations for chamber quantification: A report from the american society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr (2005); 18: 1440-1463.
6. Linhart A, Elliott PM. The heart in anderson-fabry disease and other lysosomal storage disorders. Heart (2007); 93: 528-535.
7. Linthorst GE, Vedder AC, Aerts JM, Hollak CE. Screening for fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta (2005); 353: 201-203.
8. MacDermot KD, Holmes A, Miners AH. Anderson-fabry disease: Clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet (2001); 38: 769-775.
9. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA (1999); 281: 249-254.
10. Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H. An atypical variant of fabry's disease in men with left ventricular hypertrophy. N Engl J Med (1995); 333: 288-293.
11. Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, Kanzaki T, Enriquez AL, Eng CM, Tanaka H, Tei C, Desnick RJ. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant"phenotype. Kidney Int (2003); 64: 801-807.
12. Pieroni M, Chimenti C, De Cobelli F, Morgante E, Del Maschio A, Gaudio C, Russo MA, Frustaci A. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol (2006); 47: 1663-1671.
13. Schafer E, Baron K, Widmer U, Deegan P, Neumann HP, Sunder-Plassmann G, Johansson JO, Whybra C, Ries M, Pastores GM, Mehta A, Beck M, Gal A. Thirty-four novel mutations of the GLA gene in 121 patients with fabry disease. Hum Mutat (2005); 25: 412.
14. Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, Ponzone A, Desnick RJ. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet (2006); 79: 31-40.